Nourishing better outcomes in aged care

Supporting health through evidence-based medical nutrition

A trusted partner in aged care

In aged care, where the needs of residents are complex, dynamic and evolving, nutrition plays a pivotal role in supporting health and quality of life. Nutricia is a trusted and experienced leader in medical nutrition, offering a comprehensive portfolio of scientifically backed products and services tailoured to the unique needs of older adults. The broad range of compact oral nutritional supplements (ONS), with proven compliance and flavour options, help ensure nutritional care is both effective and acceptable to residents and clients.

Our portfolio addresses the common aspects of ageing

Up to 40% of older adults living in aged care homes are malnourished¹ and up to 60% of older adults living at home in the community are at risk of malnutrition.² Malnutrition is associated with poorer and declining overall health including increased susceptibility to infection and depression, higher wound risk and delayed wound healing, higher rates of falls and fractures, as well as poorer quality of life².

Early identification and targeted nutritional support are significantly important — they may help prevent complications and support both residents and staff in their efforts to deliver consistent quality care.

Manage malnutrition with Fortisip®

Fortisip® Compact Protein is an evidence-based oral nutrition supplement specifically developed to nutritionally support older adults³⁻⁴:

• Helping meet nutritional needs³
• Increasing muscle mass⁴
• Improving functional outcomes⁴
• Improving quality of life³

These benefits, combined with Fortisip® Compact Protein’s convenient low-volume format and wide variety of flavours, can help drive greater acceptance and adherence in residential and home care settings.

Supporting early Alzheimer’s disease with Souvenaid®

Souvenaid® contains a unique combination of nutrients known as Fortasyn® Connect, formulated to nutritionally support the growth of connections within the brain, known as synapses⁵. It is currently the only Food for Special Medical Purposes (FSMP) in Australia for the dietary management of early Alzheimer’s disease, including MCI.

Backed by 20 years of evidence-based research^6-9, Souvenaid® nutritionally supports memory function in early Alzheimer’s disease when taken daily for at least 6 months^6-8.

Beyond products: A holistic support system

At Nutricia, the commitment to aged care goes beyond providing advanced nutrition products — support accessibility is available every step of the way. The dedicated Nutricia aged care team offers:

• Education and training in malnutrition, screening, nutrition and early Alzheimer’s disease
• The National Nutricia Nurse Service supports enterally fed residents and clients
• The Nutricia Careline, staffed by accredited dietitians and nutritionists for expert advice and guidance

Support at Home funding available:

Fortisip® and Souvenaid® are included and can be funded under the Support at Home program, if aligned with the patient’s identified needs, preferences and when recommended by a treating healthcare professional.

Aged Care – Adult | Nutricia managers are able to tailour solutions for all provider settings.

Order free sample: Fortisip® Compact Protein: Request a sample – Adult | Nutricia

Order free sample: Souvenaid®  

Souvenaid® and Fortisip® are food for special medical purposes and must be used under medical supervision.

Information intended for healthcare professionals and healthcare workers only, not for distribution to the general public.

References:

1. O’Shea M-C, et al. Healthcare. 2024; 12(13):1296.
2. Roberts S, et al. Nutrients. 2021; 13(7):2316. 
3. Smith TR, et al. Nutrients. 2020;12(2):517
4. Grönstedt H, et al. JAMDA. 2020;21(9):1229-1237
5. Sijben et al. OCL 2011:18;267-270
6. Scheltens P et al. Alzheimers Dement 2010; 6: 1–10.e1
7. Scheltens P et al. J Alzheimers Dis 2012; 31: 225–236
8. Soininen H, et al. Alzheimer’s Dement. 2021;17:29–40
9. Shah RC et al. Alzheimers Res Ther 2013; 5: 59